Microbot Medical Inc (NASDAQ: MBOT) on Friday, soared 5.82% from the previous trading day, before settling in for the closing price of $2.92. Within the past 52 weeks, MBOT’s price has moved between $0.82 and $3.38.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 15.51%. The company achieved an average annual earnings per share of 56.16%. With a float of $35.98 million, this company’s outstanding shares have now reached $36.38 million.
Let’s determine the extent of company efficiency that accounts for 21 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Microbot Medical Inc (MBOT) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Instruments & Supplies industry stocks is more important than anything else. The insider ownership of Microbot Medical Inc is 1.09%, while institutional ownership is 14.81%.
Microbot Medical Inc (MBOT) Recent Fiscal highlights
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.17 earnings per share (EPS) for the period topping the consensus outlook (set at -0.17) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 56.16% per share during the next fiscal year.
Microbot Medical Inc (NASDAQ: MBOT) Trading Performance Indicators
Microbot Medical Inc (MBOT) is currently performing well based on its current performance indicators. A quick ratio of 16.19 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.64, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.23 in one year’s time.
Technical Analysis of Microbot Medical Inc (MBOT)
Looking closely at Microbot Medical Inc (NASDAQ: MBOT), its last 5-days average volume was 1.68 million, which is a drop from its year-to-date volume of 3.1 million. As of the previous 9 days, the stock’s Stochastic %D was 73.93%.
During the past 100 days, Microbot Medical Inc’s (MBOT) raw stochastic average was set at 94.05%, which indicates a significant increase from 85.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.24 in the past 14 days, which was higher than the 0.19 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.60, while its 200-day Moving Average is $1.89. However, in the short run, Microbot Medical Inc’s stock first resistance to watch stands at $3.15. Second resistance stands at $3.22. The third major resistance level sits at $3.34. If the price goes on to break the first support level at $2.96, it is likely to go to the next support level at $2.84. Now, if the price goes above the second support level, the third support stands at $2.77.
Microbot Medical Inc (NASDAQ: MBOT) Key Stats
Market capitalization of the company is 112.41 million based on 36,378K outstanding shares. Right now, sales total 0 K and income totals -11,440 K. The company made 0 K in profit during its latest quarter, and -2,600 K in sales during its previous quarter.
